Associated Papers
CaMKK2 as an emerging treatment target for bipolar disorder.
Kaiser J et al.
Molecular Psychiatry, 2023
Deep exome sequencing identifies enrichment of deleterious mosaic variants in neurodevelopmental disorder genes and mitochondrial tRNA regions in bipolar disorder.
Nishioka M et al.
Molecular Psychiatry, 2023
37248276 (PubMed )
Supplement: 41380_2023_2096_MOESM2_ESM.xlsx › TableS5
Heterozygosity for neuronal ceroid lipofuscinosis predisposes to bipolar disorder.
Privitera F et al.
Revista Brasileira De Psiquiatria (sao Paulo, Brazil : 1999), 2023
35881528 (PubMed )
Supplement: 1516-4446-rbp-1516444620222650-suppl1.pdf
Systematic analysis of exonic germline and postzygotic de novo mutations in bipolar disorder.
Nishioka M et al.
Nature Communications, 2021
34145229 (PubMed )
Supplement: 41467_2021_23453_MOESM4_ESM.xlsx › Supplementary_Data_1
Functional analysis of an R311C variant of Ca2+ -calmodulin-dependent protein kinase kinase-2 (CaMKK2) found as a de novo mutation in a patient with bipolar disorder.
Xy Ling N et al.
Bipolar Disorders, 2020
Effects of Single-Nucleotide Polymorphisms in Calmodulin-Dependent Protein Kinase Kinase 2 (CAMKK2): A Comprehensive Study.
Khalid Z et al.
Computational and Mathematical Methods in Medicine, 2020
Exome sequencing for bipolar disorder points to roles of de novo loss-of-function and protein-altering mutations.
Kataoka M et al.
Molecular Psychiatry, 2016
Select a paper to view details